baber/WOPTO huggingface dataset:
Patent NZ-190888-A (NZ)
Title: Production of cross-linked addition polymer microparticles and coating compositions
Inventor: BACKHOUSE A
IPC: C08F2/08
Filed: 1979-07-02
Abstract: Crosslinked addition polymer microparticles are produced by dispersion polymerisation of monomers in an aliphatic hydrocarbon liquid in the presence of a dispersion stabiliser and also of a specified type of amino resin which is insoluble in the hydrocarbon liquid, at least one of the monomers polymerised carrying a group which can react with the amino resin under the conditions of polymerisation. Coating compositions having improved application characteristics and/or giving improved film properties are obtained by dispersing the microparticles in combinations of suitable film-forming polymers and diluents.
Patent NZ-196353-A (NZ)
Title: Device for detecting given components in air
Inventor: HEIJENGA B
IPC: G01N31/22
Filed: 1981-02-25
Abstract: The invention provides a detector for detecting air components, e.g. contaminations, and in particular noxious or poisonous contaminations, which device comprises a housing in which an air pervious carrier containing a first reagent is arranged, this detector being adapted to draw air to be tested through said carrier so as to expose this reagent to the air, this reagent being influenced by the components to be detected, which carrier is to be contacted with a second reagent which, together with the first one, can bring about a colour reaction depending on the fact whether the first reagent has been influenced or not. The housing forms, in the operative condition, an integral unit, an air- and liquid-tight container with a rupturable wall and containing a not contaminated liquid contributing to said colour reaction being arranged within said housing, the latter being, furthermore, provided with a yieldable wall portion and a plurality of piercing pins arranged in such a mutual spatial relationship that the container can be pierced by pressing inwards said wall portion, so as to moisten said reagent carrier with the liquid from said container. In particular the second reagent can be contained in a similar second carrier which is normally separated from the first one but is contacted therewith when pressing inwards said wall portion.
Patent NZ-220616-A (NZ)
Title: Intravaginal device containing 17b-estradiol and supporting matrix; method of preparation
Inventor: LINDSKOG INGA MARIANNE
IPC: A61M31/00
Filed: 1987-06-09
Abstract: The invention concerns an intravaginal device comprising a combination of 17 beta -estradiol and a supporting matrix for treating hypoestrogenic women. The device releases continously 17 beta -estradiol at a rate of about 0.5 to about 25  mu g/24 h. The invention also comprises a method of preparing the device and a method of treating hypoestrogenic women by using the device.
Patent NZ-221693-A (NZ)
Title: Delta-23-milbemycin derivatives and parasiticidal compositions
Inventor: ASATO G
IPC: A01N43/90
Filed: 1987-09-07
Abstract: The present invention relates to novel derivatives of LL-F28249 compounds wherein the 23-hydroxy group is eliminated to introduce a double bond at the 23,24 position. These resulting derivatives are DELTA <2><3>-LL-F28249 compounds. These LL-F28249 precursor compounds preferably are derived via a controlled microbiological fermentation of Streptomyces cyaneogriseus subsp. noncyanogenus having deposit accession number NRRL 15773. The novel derivatives of the present invention possess activity as anthelmintic, ectoparasitic, insecticidal, acaricidal and nematicidal agents. They also are useful in areas of human and animal health and in agricultural crops.
Patent NZ-223720-A (NZ)
Title: Dsrna/lymphokine therapy optionally using cyclooxygenase activator to increase the levels of nk (natural killer) and lak (lymphokine activated killer) cells
Inventor: CARTER WILLIAM A
IPC: A61K38/20
Filed: 1988-03-02
Abstract: The unexpected synergistic interplay between lymphokines and dsRNAs which dramatically reduces the necessary dosages of lymphokines, especially IL-2, and simultaneously widens their therapeutic range in the treatment of various types of cancers, viral disorders or other body conditions characterized by disregulated immune states (e.g., autoimmune diseases). Specific combinations of dsRNA plus IL-2 significantly increase survival in human melanoma-bearing animals in part because of augmentation by dsRNA of lymphokine activated killer cells (LAK) which are first formed in response to IL-2 exposure. The invention has wide applicability to non-toxic, efficacious control of both human cancer and various human viral infections and immunoregulatory disorders.
Patent NZ-225344-A (NZ)
Title: 3-demethylmevalonic acid derivatives and lactones and pharmaceutical compositions; intermediates for the preparation thereof
Inventor: KESSELER KURT
IPC: C07D405/06
Filed: 1988-07-08
Abstract: 3-Desmethylmevalonic acid derivatives of the formula I ( delta -lactone) or II (corresponding dihydroxycarboxylic acid derivative) 
<IMAGE>
 in which A-B, Z, R<1>, R<2>, R<3> and R<4> have the meanings given, are used as medicaments.
Patent NZ-235222-A (NZ)
Title: Inhalatory composition comprising salmeterol and beclomethasone dipropionate
Inventor: PALMER JAMES BARRY DOUGLAS
IPC: A61P37/08
Filed: 1990-09-07
Abstract: Pharmaceutical compositions comprising effective amounts of salmeterol (and/or a physiologically acceptable salt thereof) and beclomethasone dipropionate as a combined preparation for simultaneous, sequential or separate administration by inhalation in the treatment of respiratory disorders.
Patent NZ-244561-A (NZ)
Title: Locket with integral hinge pin and tongue
Inventor: SCHMID PETER
IPC: A44C3/00
Filed: 1992-09-30
Abstract: An item of jewellery, specifically a locket, is made from stamped rings or rims (36, 38) of which one has an integral pivot pin (40) and the other has a hinge tongue (52) which are formed during the stamping. To connect the rings (36, 38) the tongue 40 is simply passed behind the pin (40) and then wrapped round it. The rings (36, 38) are soldered to respective locket shells (30, 32) to complete the locket. <IMAGE>
Patent NZ-247807-A (NZ)
Title: Contact lens holder
Inventor: ALVORD LARRY ALLEN
IPC: A61L2/18
Filed: 1993-06-08
Abstract: A contact lens holding device (10) for use in a disinfecting system (48) having a single-molded piece, the piece having a dividing portion (12) having first (14) and second (16) surfaces, a first basket portion (20) integrally attached to and capable of folding into closable engagement with the first surface (14) of the dividing portion to form a first lens enclosure (28), and a second basket portion (30) integrally attached to and capable of folding into closable engagement with the second surface (16) of the dividing portion to form a second lens enclosure (42), the dividing portion (12), first basket portion (20) and second basket portion (30) lying on a substantially single plane when in unfolded configuration. <IMAGE>
Patent NZ-259565-A (NZ)
Title: Tobacco smoke filters; includes means which expands when moist, the filter being encased in a wrap and the expansion being such as to break open the wrap
Inventor: SINCLAIR NEIL MURRAY
IPC: A24D3/04
Filed: 1994-01-17
Abstract: PCT No. PCT/GB94/00086 Sec. 371 Date Jun. 30, 1995 Sec. 102(e) Date Jun. 30, 1995 PCT Filed Jan. 17, 1994 PCT Pub. No. WO94/16581 PCT Pub. Date Aug. 4, 1994The invention provides a cigarette filter (1) the biodegradation of the material (3) which is assisted by the incorporation of swellable means in the filter so that upon exposure to moisture the volume of the filter is increased, preferably to the extent of breaking open a filter wrap (2) which enclosed it.
Patent NZ-262477-A (NZ)
Title: Centre-less hole-cutting and tapping tool for use in underground petrol tank lids and rig incorporating the tool
Inventor: WHEATLEY DOUGLAS JOHN
IPC: B23G5/06
Filed: 1994-03-17
Abstract: PCT No. PCT/GB94/00544 Sec. 371 Date Oct. 30, 1995 Sec. 102(e) Date Oct. 30, 1995 PCT Filed Mar. 17, 1994 PCT Pub. No. WO94/21409 PCT Pub. Date Sep. 29, 1994A threaded hole may be formed in a lid of an underground petrol tank without emptying the tank or removing the lid, using a tool (FIG. 3) having a taper tap section (61), an intermediate tap section (62) and a final tap section (63). At the leading end of the tool, there is a reamer section (60) and supported on the free end of the tool is a centerless hole cutter (50). A resilient mounting transmits drive from the main part of the tool to the cutter (50), but allows the cutter to float. A sleeve (23) surrounds the tool, so that a column of inert gas may be caused to lie in the cutting region. A magnet (57) mounted within the cutter (50) catches and holds a released disk of the cover. Also described is a rig (FIG. 1), for operating the tool (FIG. 3), and a method (FIG. 5) of securing a collar threaded into a hole formed by the tool.
Patent NZ-263845-A (NZ)
Title: Detecting end products in a reaction scheme by observing loss of starting materials
Inventor: FOOTE NICHOLAS PETER MARTIN
IPC: C12Q1/00
Filed: 1994-04-14
Abstract: An assay device comprises a tube, a removable top part and a bottom part, wherein an elongate member with a swab at its distal end is mounted on the top part, the top part includes a compartment containing liquid and partly defined by a first frangible membrane that can be ruptured to release the liquid into the tube, and the bottom part contains a reagent and is partly defined by a second frangible membrane that can be ruptured on movement of the bottom part relative to the tube. Reaction occurring in the bottom part can be observed through a window. This reaction may be of the type involving amplification of say, ATP, e.g. by providing AMP, glucose-6-phosphate (G6P), adenylate kinase, glucokinase and reagents that convert glucose (G) to give a color, whereby the following reactions occurAMP+ATP->2ADPG6P+ADP->ATP+G.
Patent NZ-302984-A (NZ)
Title: Multifunctional enzyme having N-terminal sequence IVGGXEVTPHAYPWQVGLFIDDMYF, where X is any amino acid
Inventor: DE FAIRE JOHAN
IPC: A61P17/02
Filed: 1996-02-08
Abstract: A multifunctional enzyme derived from crustaceans or fish. The enzyme has at least one of chymotrypsin, trypsin, elastase, collagenase and exo-peptidase activity, and a molecular weight between about 20 kD and about 40 kD as determined by SDS PAGE. Preferably, the multifunctional enzyme has substantial anti cell-cell adhesion activity. Preferably, the multifunctional enzyme has substantial homology with the krill multifunctional enzyme. These enzymes are useful for treating viral infections such as herpes outbreaks, fungal, bacterial or parasitic infections, including the primary and secondary infections of leprosy, colitis, ulcers, hemorrhoids, corneal scarring, dental plaque, acne, cystic fibrosis, blood clots, wounds, immune disorders including autoimmune disease and cancer. Additionally, disclosed is a method of purifying the multifunctional enzyme, and to a preparation of essentially purified multifunctional enzyme.
Patent NZ-322369-A (NZ)
Title: Use of phosphorylated BETA H.influenzae
Inventor: MUKERJI PRADIP
IPC: A23L1/305
Filed: 1996-11-06
Abstract: A method is provided for inhibiting the attachment of Haemophilus influenzae to human pharyngeal cells by contacting the bacilli with phosphorylated recombinant human b-casein that have at least 3 phosphate groups.  A product containing phosphorylated recombinant human b-casein may be a liquid enteral nutritional product such as infant formula.  The enteral nutritional product may be used for the prevention and treatment of otis media in infants.  The phosphorylated recombinant human b-casein may also be administrated as a throat spray or used in nose drops or spray.
Patent NZ-326436-A (NZ)
Title: Ligand directed enzyme prodrug therapy for tumours using ligands that recognise and bind tumour receptors
Inventor: SPRINGER CAROLINE JOY
IPC: A61K47/48
Filed: 1997-01-24
Abstract: The invention provides a two component system for use in association with one another comprising; (a) a ligand fusion protein or conjugate with an enzyme capable of targeting the surface of a cell; and (b) a prodrug which can be converted into an active drug by said enzyme, useful in the treatment of tumours.
Patent NZ-329570-A (NZ)
Title: A large columnar body (e.g. yacht mast) formed out of a fiber-reinforced plastic comprising continuous fibers and a resin and which has three layers, one of the layers being carbon fiber
Inventor: KITANO AKIHIKO
IPC: B32B27/04
Filed: 1997-05-15
Abstract: A large-sized columnar body which is formed out of a fiber-reinforced plastic comprising continuous fibers and a resin, and which has three layers (A, B, C) laid in the mentioned order, characterized in that the reinforcing fiber in the B layer is carbon fiber arranged in the lengthwise direction of the columnar body, the fiber in the A layer and C layer being carbon fiber or/and glass fiber arranged at +/-50 to +/-70 degrees with respect to the lengthwise direction of the columnar body. This large-sized columnar body of FRP has a high compressive strength, so that the weight thereof can reduced to below that of a conventional large-sized columnar body. Accordingly, this columnar body is suitable as a primary structural material used as a building material, and for structures, aircrafts and ships. <IMAGE>
Patent NZ-333309-A (NZ)
Title: Damping combustion chamber fan motor suspension for combustion powered tool
Inventor: MOELLER LARRY
IPC: B25C1/08
Filed: 1998-12-11
Abstract: A combustion powered hand tool for driving a driver blade to drive a fastener into a work piece generates an upward axial acceleration of the combustion chamber fan motor upon a combustion in the chamber and a subsequent reciprocal axial acceleration of the motor when the piston bottoms out on the bumper.  These accelerations cause the motor to oscillate relative to the tool.  The motor is provided with a flexible ring suspension mechanism 50, 60, 70 tuned for reducing the axial acceleration of the motor and dampening the oscillation of the motor relative to the tool.
Patent NZ-334106-A (NZ)
Title: An interconnected block puzzle with triangular prism shaped blocks of equal size
Inventor: CORNELIUS BARBARA
IPC: A63F9/08
Filed: 1997-08-25
Abstract: An interconnected block puzzle comprises at least four interconnected blocks.  The blocks are equally sized and of the same triangular shaped prism.  The puzzle contains at least some blocks (for example block 53) which are hinged (at hinge lines 60 and 61) to two adjacent blocks (51, 54) in a manner illustrated in Figure 8.
Patent NZ-335643-A (NZ)
Title: Foam cleaning compositions containing polyacrylate polymer, hydrocarbon propellant, pentasodium triphosphate, ether solvent, acaricidal
Inventor: FONSNY PIERRE
IPC: A01N31/04
Filed: 1997-11-21
Abstract: A foam composition comprising by weight: a) 0.5-10% of a polyacrylate polymer; b) 2-10% of hydrocarbon propellant; c) 0.5-5% of pentasodium triphosphate; d) 0.5-3% of an ether solvent; e) 0.1-5% of at least one acaricidal agent selected from benzyl salicylate, benzyl alcohol, d-phenothrin, piperonyl butoxide, benzaldehyde, benzophenol and benzyl acetate and mixtures thereof. These compositions are used for treating dust mites.
Patent NZ-336678-A (NZ)
Title: Multi-pane sashless window with overlapping panes moveable in opposite directions
Inventor: LANGNER ROBERT CHARLES
IPC: E06B3/64
Filed: 1999-07-12
Abstract: A multi-pane sashless window comprises a frame 10 having an upper frame member, a lower frame member, side frame members and at least first and second panes 13, 14 mounted in the frame for sliding movement relative to each other and to the frame.  The first and second panes are movable from a first, closed position in which the panes 13, 14 overlap to a second position.  Movement of one of the panes in one direction causes a corresponding movement of the other pane in the opposite direction.  The panes may be movable to a second position in which there is an opening between the first and second panes.  The first and second panes may be connected by cord means extending around pulley means.  The window may comprise a top pane 11 fixed relative to the upper frame member, a bottom pane 12 fixed to the lower frame member and first and second counterbalanced panes 13, 14 mounted in the window for vertical movement relative to each other and to the frame.  The first and second counterbalanced panes may be movable into a position in which openings are formed between the fixed top pane and the counterbalanced panes and between the counter balanced panes and the fixed bottom pane.
Patent NZ-337182-A (NZ)
Title: Process for preparing eprosartan with imidazole and thiophene intermediates
Inventor: MATSUOKA RICHARD T
IPC: A61K31/4164
Filed: 1998-02-13
Abstract: A process for preparing eprosartan having the formula (I) or a pharmaceutically acceptable salt thereof comprises: a) treating a compound of formula (II) with a base followed by reaction with a regioselective nitrogen protecting reagent; b) reacting the resulting compound of formula (III) with a compound of formula (IV) in the presence of a catalyst; c) reacting the resulting compound of formula (V) with a compound of formula (VI) at elevated temperatures and thereafter hydrolyzing the R' and R"' ester groups and removing the N-3 protecting group and d) optionally forming a pharmaceutically acceptable salt. Eprosartan can also be prepared by: e) reacting a compound of formula (II) with a compound of formula (IV) in the presence of a catalyst; f) treating the resulting compound of formula (VII) with a base followed by reaction with a regioselective nitrogen protecting reagent and g) reacting the resulting compound of formula (V) with a compound of formula (VI) at elevated temperatures and thereafter hydrolyzing the R' and R"' ester groups and removing the N-3 protecting group and h) optionally forming a pharmaceutically acceptable salt. A compound of formula 2, 3, 4, 5, 6 or 7 is disclosed. In the above formulae: R1 is a nitrogen projecting group consisting of an ethylene bridge connecting the nitrogen to an electron withdrawing group or a methylene bridge connecting the nitrogen to a pivalate, 2-(trimethylsilyl)ethoxy, methoxy, tert-butoxy or benzyloxy; R', R" and R"' are independently alkyl and X is halo or OR* with R* being CH3SO2 or p-CH3-C6H4SO2-.
Patent NZ-503859-A (NZ)
Title: Non-identical minimal recombination sites (FRT) which are non-identical for targeted integration of nucleotide sequences into transformed plants
Inventor: BASZCZYNSKI CHRISTOPHER L
IPC: C12N15/31
Filed: 1998-11-17
Abstract: Methods for the targeted integration of nucleotide sequences into a plant are provided.  Transfer cassettes comprising nucleotide sequences of interest flanked by non-identical recombination sites are used to transform a plant comprising a target site.  The target site contains at least a set of non-identical recombination sites corresponding to those on the transfer cassette.  Exchange of the nucleotide sequences flanked by the recombination sites is affected by a recombinase.
Patent NZ-505233-A (NZ)
Title: Synergistic antimicrobial compositions comprising phospholipids having antimicrobial activity and another antimicrobial
Inventor: COHEN PAUL S
IPC: A01N31/02
Filed: 1998-11-20
Abstract: An antimicrobial composition comprising: i) At least one substance of formula (I), wherein Z is a phosphorus or sulfur oxyacid residue, one of R1 and R2 is -OH and the other of R1 and R2 is a saturated or unsaturated fatty acid residue with at least 7 carbon atoms and R3 is H. ii) At least one antimicrobial. The substance of formula (I) is present in an amount which enhances the effect of the at least one antimicrobial. The antimicrobial composition is useful for the treatment of bacterial, fungal, viral and protozoal infection.
Patent NZ-506211-A (NZ)
Title: Computerized medical diagnostic and treatment advice system for evaluating medical problems
Inventor: ILIFF EDWIN C
IPC: G06F19/00
Filed: 1997-07-11
Abstract: Data indicative of the symptoms of a patient over a period of time are transmitted via a communications network to an automated medical advice system and entered as one of a sequence of records into a consultation history database.  A match pattern is applied to the consultation history database to evaluate the medical problem of the patient.  If a consultation frequency value of matched records located by applying the match pattern satisfies a match threshold a recommendation of advice is generated and communicated through the communications network to the patient or the patient's advisor.  The problem data and advice might be communicated on the telephone or as data on a network to a computer terminal.
Patent NZ-506355-A (NZ)
Title: Method for modifying the swirl motion of a liquid in a swirl chamber of a nozzle and swirl generator for nozzles
Inventor: SLOWIK GUNTER
IPC: B05B1/34
Filed: 1999-03-17
Abstract: A method for modifying the swirl motion of a liquid in the swirl chamber of a nozzle and swirl generator for nozzles comprising adjustment of the mean droplet diameter at a constant volume flow rate or to maintain the droplet spectrum constant in case of adjustment of the volume flow rate.  The total fluid flow (5a, 5b) is subdivided into partial flows to be distributed across tangential supply channels (4a, 4b, 4c, 4d), which differ in terms of their cross-sections at their point of connection with the swirl chamber (3).  When the partial flows are divided across more than two tangential supply channels (4a, 4b, 4c, 4d) the cross-sections are constituted by the sum of cross-sections of the supply channels (4a, 4c or 4b, 4d) branching off the corresponding partial flow.  As a result the sums of the cross-sections at the point of connection of the partial flows with the swirl chamber (3) differ.
Patent NZ-506476-A (NZ)
Title: Substituted bisindolymaleimides for the inhibition of cell proliferation
Inventor: DHINGRA URVASHI HOODA
IPC: A61K31/40
Filed: 1999-03-10
Abstract: The compound of formula I is described wherein: R1 is hydrogen and R2 is methyl or R1 is methyl and R2 is hydrogen or R1 is hydroxymethyl and R2 is methyl and pharmaceutically acceptable salts thereof. The compound can be used in pharmaceutical compositions and for the use as an antitumor drug and for the treatment of solid tumors.
Patent NZ-510207-A (NZ)
Title: Method for treating atherosclerosis employing an aP2 inhibitor
Inventor: ROBL JEFFREY A
IPC: A61K31/421
Filed: 1999-09-13
Abstract: An aP2 inhibitor such as a substituted benzoyl, or biphenyl-2-oxazole alkanoic acid derivative, an oxazole derivative, 2-thio-4,5-diphenyl oxazole S-derivative, a phenyl-heterocyclic oxazole derivative, a diaryloxazole derivative, 4,5-diphenyloxazole derivative, an oxazole carboxylic acid derivative, a phenyloxazolyloxazole derivative, or a 2-(4,5-diaryl)-2-oxazolyl substituted phenoxyalkanoic acid  derivative is used  to treat atherosclerosis.  The aP2 inhibitor can binds to the aP2 protein and inhibits its function and/or its ability to bind free fatty acids.
Patent NZ-510678-A (NZ)
Title: Antiparasitic formulations containing avermectin and di-glycol monomethyl ether
Inventor: WICKS STEPHEN RICHARD
IPC: A01N25/00
Filed: 1999-10-20
Abstract: A long-acting antiparasitic formulation suitable for topical application is disclosed, which includes: (a) 0.1-50 % w/v 13-monosaccharide 5-oxime: (b) 1-50 % v/v a di(C2-4 glycol) mono(C1-4 alkyl) ether; (c) an optional antioxidant; and (d) an optional skin acceptable volatile solvent q.s. v/v.
Patent NZ-512980-A (NZ)
Title: Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation
Inventor: CATES GEORGE A
IPC: A61K39/00
Filed: 1999-12-16
Abstract: A multivalent immunogenic composition comprising: a purified fusion protein containing the matrix protein of the respiratory syncytial virus (RSV) and a non-virulent influenza virus preparation.